JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee


These guidelines form a constituent part of Chapter 22 (haemopoietic progenitor cells) of the Guidelines for the Blood Transfusion Services in the United Kingdom.

The criteria are reviewed regularly to ensure that the stem cells obtained are of the highest quality and of sufficient quantity to meet the needs of recipients.

JPAC is responsible for this document and receives professional advice from the Standing Advisory Committees (SACs) that form part of its structure and from other relevant expert groups.

Users of these guidelines must ensure that they have the latest version and that recent changes have been implemented (usually within three months) by their national service.

Latest Updates lists alterations to the guidelines made since publication of this edition.

Comments about the content of these guidelines, including notification of errors, omissions and suggestions for improvements, should be sent to the Chair of SAC-Tissues and Cellular Therapy Products:

Dr Akila Chandrasekar


Last updated 19/04/2024